Prioritize Children When Developing Antibacterial Agents

  17 June 2022

There is a significant lag time before determining the appropriate dosing regimen for new antibacterial agents given to children.

Of the 24 approved antimicrobials, 20 were for use in adults alone for indications that included acute bacterial skin infections and community-acquired pneumonia. Of those 20, six were approved and labeled for patients younger than 18 years old, with the period of approval for adults and children ranging from 20 to 195 months. In addition, 11 of the 14 that have not been labeled for children have yet to complete PREA requirements.

Further reading: IDSE
Author(s): Aaron Tallent
Kids and Carers  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!